Post-left atrial appendage occlusion, apixaban use was associated with a significantly lower risk of thromboembolic events compared to other antithrombotics.
Tasa de eventos absoluta: 0% vs 0%
Figure: see text
Sandeep K. Goyal (Thu,) reported a other. Post-left atrial appendage occlusion, apixaban use was associated with a significantly lower risk of thromboembolic events compared to other antithrombotics.